Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use | Zendy

Marco Cicardi | Zendy; Lorenza C. Zingale | Zendy; Luigi Bergamaschini | Zendy; A Agostoni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use

Author(s) -

Marco Cicardi,

Lorenza C. Zingale,

Luigi Bergamaschini,

A Agostoni

Publication year - 2004

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.164.8.910

Subject(s) - angioedema , medicine , ace inhibitor , angiotensin converting enzyme , adverse effect , c1 inhibitor , gastroenterology , blood pressure

Angiotensin-converting enzyme (ACE) inhibitors are associated with angioedema episodes that are potentially life-threatening. Few data are available on the outcome of patients reporting this adverse effect when they are switched to another drug. Scattered reports of angioedema associated with angiotensin II receptor blocker (ARB) use question the safety of using these drugs in patients with ACE inhibitor-related angioedema. We describe 64 consecutive patients with ACE inhibitor-related angioedema, the outcome after discontinuing this treatment, and the safety of using ARBs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research